Kelonia Therapeutics

0 followers


Kelona is revolutionizing gene delivery to expand the impact of genetic medicines.

Their goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.

Industries

Employees

11-50

Links

Org chart

Kevin Friedman
Chief Scientific Officer & President

Kevin Friedman

Collapse
Michael McDonald
SVP & Head, IP & Legal Affairs
Travis Quigley
SVP, Clinical Development
Laura Sandler
SVP, Strategic Operations
Ryan Lynch
VP, Finance
Stacy Gilroy
VP, Talent & Culture
Shannon Grande Contrastano
Senior Director, Preclinical Sciences
Emily Beura
Associate Director, T Cell Biology
Ricky Lane
Associate Director, Analytical Development